Physician
Katharine H Mikulec, M.D.
According to 2025 Medicare claims, Katharine Mikulec, M.D. (NPI: 1336254887) practices endocrinology in the St. Louis, MO-IL market, with the plurality of this provider's patient population coming from St. Louis, MO. This provider's primary affiliated billing organization is THE OSTEOPOROSIS CENTER AT ST. LUKE'S HOSPITAL, LLC (NPI: 1306088182; TIN: 263962089) and primary practice location at 63017-3509. Mikulec is affiliated with the St. Luke's ACO, LLC (ACO ID: A3623) and The Rural Advantage LLC (ACO ID: A5257), participating under the MSSP model.
Mikulec's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 739 traditional Medicare patients, billed 65,836 HCPCS/CPT codes, and received $1,049,868 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,345 prescription claims across 391 beneficiaries totaling $572,772 in drug costs, led by Tymlos (Abaloparatide). Open Payments data shows 35 records totaling $644. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.
Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $64,044 to $1,049,868. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $254,288 and ending at $572,772. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.